Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,953 | 86,308 | 93,311 | 103,710 | 85,985 |
| Marketable Securities | 23,667 | 27,564 | 27,242 | 23,051 | 44,709 |
| Receivables | 527 | 416 | 154 | 163 | 184 |
| TOTAL | $110,502 | $115,167 | $122,105 | $127,560 | $132,091 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 248 | 529 | 552 | 575 |
| TOTAL | $N/A | $248 | $529 | $552 | $575 |
| Total Assets | $110,502 | $115,415 | $122,634 | $128,112 | $132,666 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,600 | 1,589 | 3,562 | 3,177 | 3,463 |
| TOTAL | $1,600 | $1,715 | $3,687 | $3,301 | $3,575 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 154 | 180 | 205 | 230 |
| TOTAL | $N/A | $154 | $180 | $205 | $230 |
| Total Liabilities | $1,600 | $1,869 | $3,867 | $3,506 | $3,805 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,308 | 44,389 | 44,389 | 44,389 | 44,369 |
| Common Shares | 279,862 | 279,862 | 279,862 | 279,862 | 279,752 |
| Retained earnings | -226,914 | -222,911 | -216,536 | -208,004 | -201,649 |
| Other shareholders' equity | -2,097 | -2,090 | -2,072 | -2,063 | -2,100 |
| TOTAL | $108,902 | $113,547 | $118,767 | $124,606 | $128,862 |
| Total Liabilities And Equity | $110,502 | $115,415 | $122,634 | $128,112 | $132,666 |